Publication | Closed Access

Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors

Medicinal ChemistryMedicineNatural SciencesPharmacologyRational Drug DesignPharmacotherapyAnti-cancer AgentChemistryDrug DevelopmentMolecular DockingHydrazone-coupled DerivativesDrug DiscoverySilico Admet Profile